Company · CIK 1830487
Pharvaris N.V.
| CIK | 1830487 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | P7 |
| Listed | PHVS (Nasdaq) |
| First annual or quarterly report | 2021-04-29 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-263198 | 2022-03-02 | 2023-12-07 | 4 | |
| 333-273757 | 2023-08-07 | 2023-08-24 | 3 | |
| 333-252157 | 2021-01-15 | 2021-02-08 | 5 |
Filings
16| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-05-08 | 424B5Shelf takedown | 333-278650 | 0001193125-26-214985 |
| 2025-07-24 | 424B5Shelf takedown | 333-278650 | 0001193125-25-163778 |
| 2025-07-22 | 424B5Shelf takedown | 333-278650 | 0001193125-25-162585 |
| 2023-12-07 | 424B5Shelf takedown | 333-263198 | 0001193125-23-290712 |
| 2023-08-24 | 424B5Shelf takedown | 333-273757 | 0000950170-23-044372 |
| 2023-08-16 | EFFECTDeclared effective | 333-273757 | 9999999995-23-002409 |
| 2023-08-07 | F-3Shelf registered | 333-273757 | 0000950170-23-038813 |
| 2022-03-15 | 424B5Shelf takedown | 333-263198 | 0001193125-22-076044 |
| 2022-03-10 | EFFECTDeclared effective | 333-263198 | 9999999995-22-000617 |
| 2022-03-02 | F-3Shelf registered | 333-263198 | 0001193125-22-061867 |
| 2021-02-08 | 424B4Final prospectus | 333-252157 | 0001193125-21-032407 |
| 2021-02-04 | EFFECTDeclared effective | 333-252157 | 9999999995-21-000442 |
| 2021-02-01 | F-1/AAmendment | 333-252157 | 0001193125-21-023578 |
| 2021-01-22 | F-1/AAmendment | 333-252157 | 0001193125-21-014933 |
| 2021-01-15 | F-1Registration filed | 333-252157 | 0001193125-21-010126 |
| 2020-11-12 | DRSDraft made public | 377-03769 | 0000950123-20-011234 |